From a group of TKI-resistant CML patients, we identified a 2.9 kb intronic deletion in the BIM gene, and later verified it to be a polymorphism found in 12.3% of East Asians [17]. Here, BCL2L11 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.